Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia
The ATM-p53 DNA damage response pathway plays a crucial role in chemoresistance in chronic lymphocytic leukemia, as indicated by the adverse prognostic impact of deletions of 17p (locus of TP53) and 11q (locus of ATM) detected by fluorescence in situ hybridization (FISH) analysis. In addition to del...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 Jun 2013
|
| In: |
Leukemia and lymphoma
Year: 2013, Volume: 54, Issue: 8, Pages: 1849-1853 |
| ISSN: | 1029-2403 |
| DOI: | 10.3109/10428194.2013.796058 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2013.796058
|
| Author Notes: | G. Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, Martin Trbusek, Mark Mraz, Maria Le Garff-Tavernier, Hélène Merle-Béral, Ke Lin, Andrew R. Pettitt, Olaf Merkel, Tatjana Stankovic, Marinus H. van Oers, Eric Eldering, Stephan Stilgenbauer, Thorsten Zenz, Arnon P. Kater |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1788425391 | ||
| 003 | DE-627 | ||
| 005 | 20230426162732.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220203s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/10428194.2013.796058 |2 doi | |
| 035 | |a (DE-627)1788425391 | ||
| 035 | |a (DE-599)KXP1788425391 | ||
| 035 | |a (OCoLC)1341441280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Raa, G. Doreen te |e VerfasserIn |0 (DE-588)1078685436 |0 (DE-627)839137133 |0 (DE-576)451602730 |4 aut | |
| 245 | 1 | 0 | |a Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia |c G. Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, Martin Trbusek, Mark Mraz, Maria Le Garff-Tavernier, Hélène Merle-Béral, Ke Lin, Andrew R. Pettitt, Olaf Merkel, Tatjana Stankovic, Marinus H. van Oers, Eric Eldering, Stephan Stilgenbauer, Thorsten Zenz, Arnon P. Kater |
| 264 | 1 | |c 24 Jun 2013 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.02.2022 | ||
| 520 | |a The ATM-p53 DNA damage response pathway plays a crucial role in chemoresistance in chronic lymphocytic leukemia, as indicated by the adverse prognostic impact of deletions of 17p (locus of TP53) and 11q (locus of ATM) detected by fluorescence in situ hybridization (FISH) analysis. In addition to deletions, mutations in these respective genes are also associated with chemoresistance, and add to the prognostic information provided by FISH. In order to explore the possibility that dysfunction of the ATM-p53 pathway might also result from mechanisms other than ATM/TP53 deletion/mutation, assays have been developed that probe the functional integrity of the ATM-p53 pathway. Currently, four different p53 function assays have been developed that are based on the measurement of p53 and p53-dependent genes at the RNA (real-time polymerase chain reaction [RT-PCR]p21; RT-PCRmiR34a; reverse transcription-multiplex ligation-dependent probe amplification assay [RT-MLPA]p21, bax, puma and CD95) or protein (fluorescence activated cell sorting [FACS]p53-p21) level in untreated cells or following irradiation or drug treatment. Here we provide an overview of these assays based on the available literature. | ||
| 650 | 4 | |a ATM | |
| 650 | 4 | |a Chronic lymphocytic leukemia | |
| 650 | 4 | |a DNA damage response | |
| 650 | 4 | |a p53 axis | |
| 650 | 4 | |a p53 function assays | |
| 650 | 4 | |a TP53 | |
| 700 | 1 | |a Malcikova, Jitka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pospisilova, Sarka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trbusek, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mraz, Mark |e VerfasserIn |4 aut | |
| 700 | 1 | |a Garff-Tavernier, Maria Le |e VerfasserIn |4 aut | |
| 700 | 1 | |a Merle-Béral, Hélène |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lin, Ke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pettitt, Andrew R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Merkel, Olaf |d 1969- |e VerfasserIn |0 (DE-588)121367008X |0 (DE-627)1724479008 |4 aut | |
| 700 | 1 | |a Stankovic, Tatjana |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Oers, Marinus H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eldering, Eric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stilgenbauer, Stephan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zenz, Thorsten |d 1970- |e VerfasserIn |0 (DE-588)114963738 |0 (DE-627)577184202 |0 (DE-576)180278266 |4 aut | |
| 700 | 1 | |a Kater, Arnon P. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia and lymphoma |d London [u.a.] : Taylor & Francis Group, 1989 |g 54(2013), 8, Seite 1849-1853 |h Online-Ressource |w (DE-627)324746237 |w (DE-600)2030637-4 |w (DE-576)099718170 |x 1029-2403 |7 nnas |a Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia |
| 773 | 1 | 8 | |g volume:54 |g year:2013 |g number:8 |g pages:1849-1853 |g extent:5 |a Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.3109/10428194.2013.796058 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220203 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 114963738 |a Zenz, Thorsten |m 114963738:Zenz, Thorsten |p 15 | ||
| 998 | |g 121367008X |a Merkel, Olaf |m 121367008X:Merkel, Olaf |p 10 | ||
| 999 | |a KXP-PPN1788425391 |e 4050697343 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia","title":"Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia"}],"person":[{"display":"Raa, G. Doreen te","roleDisplay":"VerfasserIn","role":"aut","family":"Raa","given":"G. Doreen te"},{"roleDisplay":"VerfasserIn","display":"Malcikova, Jitka","role":"aut","family":"Malcikova","given":"Jitka"},{"given":"Sarka","family":"Pospisilova","role":"aut","display":"Pospisilova, Sarka","roleDisplay":"VerfasserIn"},{"family":"Trbusek","given":"Martin","display":"Trbusek, Martin","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Mraz, Mark","roleDisplay":"VerfasserIn","given":"Mark","family":"Mraz"},{"family":"Garff-Tavernier","given":"Maria Le","roleDisplay":"VerfasserIn","display":"Garff-Tavernier, Maria Le","role":"aut"},{"display":"Merle-Béral, Hélène","roleDisplay":"VerfasserIn","role":"aut","family":"Merle-Béral","given":"Hélène"},{"display":"Lin, Ke","roleDisplay":"VerfasserIn","role":"aut","family":"Lin","given":"Ke"},{"family":"Pettitt","given":"Andrew R.","display":"Pettitt, Andrew R.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Merkel","given":"Olaf","display":"Merkel, Olaf","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Tatjana","family":"Stankovic","role":"aut","roleDisplay":"VerfasserIn","display":"Stankovic, Tatjana"},{"role":"aut","display":"van Oers, Marinus H.","roleDisplay":"VerfasserIn","given":"Marinus H.","family":"van Oers"},{"family":"Eldering","given":"Eric","display":"Eldering, Eric","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Stilgenbauer, Stephan","role":"aut","family":"Stilgenbauer","given":"Stephan"},{"family":"Zenz","given":"Thorsten","roleDisplay":"VerfasserIn","display":"Zenz, Thorsten","role":"aut"},{"family":"Kater","given":"Arnon P.","display":"Kater, Arnon P.","roleDisplay":"VerfasserIn","role":"aut"}],"note":["Gesehen am 03.02.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1788425391","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"24 Jun 2013"}],"id":{"doi":["10.3109/10428194.2013.796058"],"eki":["1788425391"]},"name":{"displayForm":["G. Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, Martin Trbusek, Mark Mraz, Maria Le Garff-Tavernier, Hélène Merle-Béral, Ke Lin, Andrew R. Pettitt, Olaf Merkel, Tatjana Stankovic, Marinus H. van Oers, Eric Eldering, Stephan Stilgenbauer, Thorsten Zenz, Arnon P. Kater"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"title":[{"title":"Leukemia and lymphoma","title_sort":"Leukemia and lymphoma"}],"disp":"Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaLeukemia and lymphoma","note":["Gesehen am 08.09.15"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"324746237","pubHistory":["1.1989/90 -"],"part":{"issue":"8","pages":"1849-1853","year":"2013","extent":"5","text":"54(2013), 8, Seite 1849-1853","volume":"54"},"origin":[{"dateIssuedDisp":"1989-","dateIssuedKey":"1989","publisher":"Taylor & Francis Group ; Informa Healthcare","publisherPlace":"London [u.a.] ; London [u.a.]"}],"id":{"issn":["1029-2403"],"zdb":["2030637-4"],"eki":["324746237"]},"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a RAAGDOREENOVERVIEWOF2420 | ||